InTRoduCTIon
Atrial fibrillation (AF) affects millions of people worldwide. (1) It is already known several decades that AF is not a benign condition, and it's associated with a 5-fold increased risk of stroke, 3-fold increased risk of heart failure, and doubling of risk of dementia and death.(2-4) Myocardial infarction, and coronary heart disease, are traditional risk factors of AF,(5) however, whether myocardial infarction is a consequence of AF, has not been studied in great detail yet. The focus of current treatment for AF is pointed towards prevention of stroke. This is of utmost importance; however the other cardiovascular morbidities and mortality should not be overseen. An analysis of patients originally diagnosed with idiopathic AF, demonstrated that these patients develop frequently cardiovascular disease, including myocardial infarction and coronary artery disease.(6) An analysis of Medicare data emphasized the importance of cardiovascular events beyond stroke, such as heart failure, myocardial infarction and death in older adults with AF. (7) In the current issue of Circulation, Soliman et al. describe the association of AF with myocardial infarction.(8) Similar findings in 2 other cohorts by the same lead author have been published in the last months.(9,10) First, the analysis of 23,928 US residents without coronary heart disease included in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort demonstrated that prevalent AF was associated with a 2-fold higher incidence of myocardial infarction.(9) Risk of myocardial infarction was significantly higher in women and blacks. Second, the analysis from the Cardiovascular Health Study (CHS) showed similar associations.(10) Third, in current issue of Circulation, (8) Soliman and colleagues present an analysis of 14,462 participants who were free of coronary heart disease at baseline, included in the Atherosclerosis Risk in Communities (ARIC) study. The authors investigated the association of AF as a timevarying variable (n=1545) with overall incident myocardial infarction, and by type of myocardial infarction (ST elevation myocardial infarction [STEMI] or non-ST elevation myocardial infarction [NSTEMI]). Atrial fibrillation was associated with a 63% increase in risk of myocardial infarction after multivariable adjustments. The association was limited to NSTEMI; no association with STEMI was found. In accordance with REGARDS, women had higher risks of developing myocardial infarction, than men. Racial differences did not reach statistical significance here.
How can we explain the recent findings in several independent cohorts? Is it because the prevalence of both AF and myocardial infarction are increasing, and is it a matter of time until both conditions happen in the same individual? Or is it because the highsensitive troponin assays enhance the detection of minimal myocardial damage, and the diagnosis of myocardial infarction, especially NSTEMI, is made more often than in the old days, and may even represent myocardial damage as result of AF itself rather than result of atherosclerosis?(11) However, there are also other possible explanations.
Firstly, both AF and myocardial infarction share many cardiovascular risk factors including age, hypertension and diabetes mellitus. (12) Possibly the association of AF and myocardial infarction reflects a final common pathway of underlying vascular disease. Extrapolating ideas from the relation of AF and stroke to the relation of AF and myocardial infarction may be of value to support this notion. There has always been a strong belief that AF, clot formation and stroke are temporally linked, especially since this fits Virchov's trias with low flow, increased plasma clotting factors and vessel wall, i.e. atrial wall abnormalities. However, the ASymptomatic AF and Stroke Evaluation in pacemaker patients and the AF Reduction atrial pacing (ASSERT) Trial has recently shown that there is a temporal disconnect between stroke and continuously monitored occurrence of AF. (13) This suggests that stroke, and probably also myocardial infarction, and AF have pathophysiological mechanisms in common. This is also reflected by the CHA 2 DS 2 -VASc score, the risk of stroke depends on the number of cardiovascular conditions present in patients with a diagnosis of AF, and not on the number of AF recurrences after the initial diagnosis.(2,3) However, the explanation of shared risk factors, and common pathways, negates the complex relations between AF and myocardial infarction. Myocardial infarction, and transient ischemia, may beget AF. (14) Myocardial infarction, and coronary heart disease, are well-established risk factors for incident AF, (12) and subclinical coronary artery disease also increases AF risk, potentially via atrial remodeling or transient ventricular ischemia with atrial diastolic overload.(5,15) Studies investigating oral anticoagulants in AF suggested an increased risk of myocardial infarction in patients with AF, (16, 17) and it has been suggested that there are differences between the diverse oral anticoagulants in reducing risk of myocardial infarction. (18, 19) The opposite, AF may beget myocardial infarction also seems true, as was convincingly demonstrated by the studies authored by Soliman.(8-10) Atrial fibrillation may lead to myocardial infarction through increased heart rate and thus increased oxygen demand, sympathetic activation, endothelial dysfunction, and pro-inflammatory and pro-thrombotic effects ( figure  1).(14) The finding that NSTEMI, but not STEMI was associated with AF, supports the notion that recurrent ischemia is more frequently associated with NSTEMI compared to STEMI. However, coronary angiograms, which might substantiate this, were not routinely done in present community-based studies.(8-10) Also, coronary stenosis or occlusion on coronary angiograms or performed percutaneous coronary interventions were not essential for the diagnosis of myocardial infarction in these cohorts.
Previously, strict implementation of AF guidelines using nurse-led care has shown to improve overall AF-related outcomes, including cardiovascular events beyond stroke. (20) Currently, the IntegRAted CarE for Atrial Fibrillation (RACE-4) study, a randomized multicenter study in the Netherlands, is recruiting up to 1716 patients to further study whether strict evaluation and follow-up of individuals with AF by specialized nurses can improve AF-related outcomes. It is also a call for more research to better understand the causality of both conditions, and the underlying pathophysiology. This cannot be established from present community-based cohort studies. 
